Page last updated: 2024-09-05
zm 241385 and zd 7155
zm 241385 has been researched along with zd 7155 in 1 studies
Compound Research Comparison
| Studies (zm 241385) | Trials (zm 241385) | Recent Studies (post-2010) (zm 241385) | Studies (zd 7155) | Trials (zd 7155) | Recent Studies (post-2010) (zd 7155) |
|---|---|---|---|---|---|
| 401 | 3 | 124 | 43 | 0 | 8 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Carlström, M; Lai, EY; Patzak, A; Persson, AE | 1 |
Other Studies
1 other study(ies) available for zm 241385 and zd 7155
| Article | Year |
|---|---|
Angiotensin II enhances the afferent arteriolar response to adenosine through increases in cytosolic calcium.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arterioles; Calcium; Cytosol; Kidney; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Naphthyridines; Purines; Receptor, Adenosine A1; Receptor, Angiotensin, Type 1; Receptors, Adenosine A2; Triazines; Triazoles; Vasoconstriction | 2009 |